The global gene editing market is growing with more than 15% CAGR and what propels it are multiple applications; from drug discovery processes and high-value personalized medicines to microorganisms and plant genetic engineering. Another market driver are increasingly accessible gene editing tools. CRISPR/Cas is an important one, holding about 50% of the market due to its multiplexing ability and a relatively easy design. It consists out of an endonuclease, called Cas9, and an engineered chimeric guide RNA that matches DNA sequence of interest. The technology has significant potential of use and any advancement is highly desired.